TENX · Forms 3, 4, 5
Insider trades at TENAX THERAPEUTICS, INC.
4 insiders bought $4.9M of TENAX THERAPEUTICS, INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for TENAX THERAPEUTICS, INC. (TENX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Declan Doogan | Director | Buy | 53,000 | $1.92 | $102K | Form 4 | |
| Christopher Thomas Giordano | CEO | Buy | 4,850 | $1.82 | $9K | Form 4 | |
| Christopher Thomas Giordano | CEO | Buy | 6,000 | $1.88 | $11K | Form 4 | |
| Thomas R Staab II | Chief Financial Officer | Buy | 5,675 | $1.94 | $11K | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 900,000 | $1.78 | $1.6M | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 187,704 | $1.80 | $338K | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 179,058 | $1.80 | $322K | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 403,571 | $1.79 | $723K | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 107,374 | $1.75 | $188K | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| ADAR1 Capital Management, LLC | 10% owner | Buy | 716,369 | $1.77 | $1.3M | Form 4 | |
| ADAR1 Capital Management, LLC | 10% owner | Buy | 202,124 | $1.78 | $360K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.